#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Chris Coletta Email
Head Development, Precision Delivery . Alcyone Therapeutics
How to contact Chris Coletta
Join and see Chris's contact info for free!Current Roles
Employees:
41Revenue:
$6.4MAbout
Alcyone Therapeutics is a biotechnology company developing precision therapies for neurological disorders with high unmet medical needs. The company integrates innovation in neuroscience, precision dosing platforms and in-house manufacturing capabilities to deliver transformative therapies to patients. Alcyone leverages the synergy between FalconTM, the company’s proprietary intrathecal precising dosing platform that incorporates deep knowledge of CSF fluid dynamics, computational modeling and bioengineering, and multiple novel genetic therapy platforms developed at the Abigail Wexner Research Institute at Nationwide Children’s Hospital (AWRI). This comprehensive approach allows for the optimization of central nervous system (CNS) dosing and delivery to better target the pathophysiology and anatomy specific to various neurological disease areas. Alcyone’s lead programs target the treatment of Rett syndrome and IGHMBP2-Related Diseases (IRD).Alcyone Therapeutics Address
116 John StLowell, MA
United States